Skip to main content
. 2024 Jun 18;13(6):514. doi: 10.3390/pathogens13060514

Figure 12.

Figure 12

Subsets of TFH cells prior to and following 1st dose and 2nd doses of SARS-CoV-2 vaccine. Basal levels of TFH1 were higher and remained high after vaccination in CVID. TFH2 were markedly reduced after the 1st dose in HC, whereas they were modestly reduced in CVID. TFH1/17 increased after the 1st dose in HC, whereas in CVID, two of three subjects showed no increase.